CEO
EpimAb Biotherapeutics, Inc.
Shanghai, Shanghai
Chengbin Wu serves as CEO at EpimAb Biotherapeutics, Inc.. EpimAb Biotherapeutics, Inc. operates in the biotechnology sector with approximately 40.0 employees. The company is headquartered in Shanghai, Shanghai. EpimAb Biotherapeutics, Inc. generates annual revenue of 9300000.0. To date, EpimAb Biotherapeutics, Inc. has raised 219000000.0 in total funding, with the most recent round being Series C.
Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Chengbin Wu, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.
Chengbin Wu's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at EpimAb Biotherapeutics, Inc.. Access direct contact info to skip gatekeepers and reach the decision maker.
Chengbin Wu is CEO at EpimAb Biotherapeutics, Inc., a company in the biotechnology sector with 40.0 employees. The company is based in Shanghai, Shanghai.
As CEO at EpimAb Biotherapeutics, Inc., Chengbin Wu is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Chengbin Wu directly — ideal for B2B sales, partnerships, and executive recruiting.
Chengbin Wu works in the biotechnology industry as CEO at EpimAb Biotherapeutics, Inc.. MessageCEO provides verified contact information for executives across all major industries.
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Chengbin Wu's profile is kept up-to-date with the latest available information.